23Rac proteins, members of the Rho family of small GTP-binding proteins, have been 24 implicated in transducing a number of signals for various biological mechanisms, 25 including cell cytoskeleton organization, transcription, proliferation, migration, and 26 cancer cell motility. Among human cancers, Rac proteins are highly activated by either 27 overexpression of the genes, up-regulation of the protein, or by mutations that allow the 28 protein to elude normal regulatory signaling pathways. Rac proteins are involved in 29 controlling cell survival and apoptosis. The effects of Rac inhibition by the Rac-specific 30 small molecule inhibitor NSC23766 or by transfection of dominant negative Rac (Rac-31 DN) were examined on three human-derived oral squamous cell carcinoma cell lines 32 that exhibit different malignancy grades, OSC-20 (grade 3), OSC-19 (grade 4C), and 33 HOC313 (grade 4D). Upon suppression of Rac, OSC-19 and HOC313 cells showed 34 significant decreases in Rac activity and resulted in condensation of the nuclei and up-35 regulation of c-Jun N-terminal kinase (JNK), leading to caspase-dependent apoptosis. In 36 contrast, OSC-20 cells showed only a slight decrease in Rac activity, which resulted in 37 slight activation of JNK and no change in the nuclei. Fibroblasts treated with 38 NSC23766 also showed only a slight decrease in Rac activity with no change in the 39 nuclei or JNK activity. Our results indicated that apoptosis elicited by the inhibition of 40 Rac depended on the extent of decreased Rac activity and the malignant state of the 41 squamous cell carcinoma. In addition, activation of JNK strongly correlated with 42 apoptosis. Rac inhibition may represent a novel therapeutic approach for cancer 43 treatment.44